Edward M. Gillis's most recent trade in BioCardia Inc. was a trade of 38,078 Common Stock done at an average price of $1.4 . Disclosure was reported to the exchange on Dec. 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioCardia Inc | Edward M. Gillis | Senior Vice President, Devices | Grant, award, or other acquisition of securities at price $ 1.37 per share. | 08 Dec 2025 | 38,078 | 47,046 (0%) | 0% | 1.4 | 52,167 | Common Stock |
| BioCardia Inc | Edward M. Gillis | Senior Vice President, Devices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 20,000 | 31,697 | - | - | Stock Option (right to buy) | |
| BioCardia Inc | Edward M. Gillis | Senior Vice President, Devices | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.37 per share. | 08 Dec 2025 | 15,172 | 31,874 (0%) | 0% | 1.4 | 20,786 | Common Stock |
| BioCardia Inc | Edward M. Gillis | Senior Vice President, Devices | Sale of securities on an exchange or to another person at price $ 2.00 per share. | 20 Dec 2024 | 3,257 | 8,968 (0%) | 0% | 2 | 6,514 | Common Stock |
| BioCardia Inc | Edward M. Gillis | Senior Vice President, Devices | Grant, award, or other acquisition of securities at price $ 2.65 per share. | 11 Oct 2024 | 15,808 | 19,065 (0%) | 0% | 2.6 | 41,891 | Common Stock |
| BioCardia Inc | Edward M. Gillis | Senior Vice President, Devices | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 11 Oct 2024 | 6,840 | 12,225 (0%) | 0% | 2.7 | 18,126 | Common Stock |
| BioCardia Inc | Edward M. Gillis | Senior Vice President, Devices | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.77 per share. | 31 May 2023 | 15,512 | 48,857 (0%) | 0% | 1.8 | 27,456 | Common Stock |
| BioCardia Inc | Edward M. Gillis | Senior Vice President, Devices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 43,803 | 43,803 | - | - | Stock Option (right to buy) | |
| BioCardia Inc | Edward M. Gillis | Senior Vice President, Devices | Grant, award, or other acquisition of securities at price $ 1.70 per share. | 18 May 2023 | 40,490 | 40,490 (0%) | 0% | 1.7 | 68,833 | Common Stock |
| BioCardia Inc | Edward M. Gillis | Senior Vice President, Devices | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.32 per share. | 12 May 2022 | 12,358 | 23,879 (0%) | 0% | 1.3 | 16,313 | Common Stock |
| BioCardia Inc | Edward M. Gillis | Senior Vice President, Devices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2022 | 38,000 | 38,000 | - | - | Stock Option (right to buy) | |
| BioCardia Inc | Edward M. Gillis | Senior Vice President, Devices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2022 | 30,155 | 36,237 (0%) | 0% | 0 | Common Stock | |
| BioCardia Inc | Edward M. Gillis | Senior Vice President, Devices | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.35 per share. | 10 Jun 2021 | 9,953 | 6,082 (0%) | 0% | 4.4 | 43,296 | Common Stock |
| BioCardia Inc | Edward M. Gillis | Senior Vice President, Devices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2021 | 48,670 | 48,670 | - | - | Stock Option (right to buy) | |
| BioCardia Inc | Edward M. Gillis | Senior Vice President, Devices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2021 | 9,953 | 9,953 (0%) | 0% | 0 | Common Stock |